Fusion Pharma: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement

(marketscreener.com) HAMILTON, ON and BOSTON, May 31, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines, today announced it has obtained a final order from the Ontario Superior Court of Justice approving the previously announced statutory plan...https://www.marketscreener.com/quote/stock/FUSN-PHAR-108985405/news/Fusion-Pharmaceuticals-Receives-Final-Court-Order-Approving-Arrangement-46877940/?utm_medium=RSS&utm_content=20240531